Cases & Deals

Astellas Pharma acquires Ogeda SA for €800 million (US$852 million)

Clients Astellas Pharma Inc.

Jones Day advised Astellas Pharma Inc., a Japanese leader in the pharma industry, in its €800 million (US$852 million) acquisition of Ogeda SA, a privately owned Belgian drug discovery company.

In addition to M&A representation, Jones Day provided antitrust and intellectual property advice regarding this transaction.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.